Mutations that lead to muscle atrophy can be repaired with the gene editor CRISPR-Cas9. A team led by ECRC researcher Helena Escobar has now introduced the tool into human muscle stem cells for the first time using mRNA, thus discovering a method suitable for therapeutic applications.
Click here for original story, A potential therapy for muscular dystrophy: Using mRNA delivery to improve muscle strength
Source: Phys.org